Altmetric – Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK

Title	Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”
Published in	Trials, June 2021
DOI	10.1186/s13063-021-05340-3
Pubmed ID	34090495
Authors	Hanne Bruhn, Annie S. Anderson, Amy Hickman, E. Jane Macaskill, Shaun Treweek

X Demographics

The data shown below were collected from the profiles of 50 X users who shared this research output. Click here to find out more about how the information was compiled.

Type	Count	As %
Members of the public	29	58%
Scientists	10	20%
Practitioners (doctors, other healthcare professionals)	9	18%
Science communicators (journalists, bloggers, editors)	2	4%

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	21	100%

Readers by professional status	Count	As %
Researcher	4	19%
Other	2	10%
Student > Ph. D. Student	2	10%
Lecturer	2	10%
Lecturer > Senior Lecturer	1	5%
Other	2	10%
Unknown	8	38%

Readers by discipline	Count	As %
Social Sciences	3	14%
Medicine and Dentistry	3	14%
Pharmacology, Toxicology and Pharmaceutical Science	2	10%
Computer Science	1	5%
Arts and Humanities	1	5%
Other	2	10%
Unknown	9	43%

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”